2024-11-23 09:36:21
Invivoscribe Launches COVID-19 Diagnostic Testing With Option To Participate In SARS-CoV-2 Antibody And Vaccine Program
Health/ 2023-07-22
Invivoscribe Launches COVID-19 Diagnosti...

SAN DIEGO,April 28,2020-- Invivoscribe,Inc.,a global leader in the development and commercialization of precision diagnostics announced toda...

PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
Corporate/ 2023-07-23
PharmaMar Has Announced That the Spanish...

- The objective of the trial is to evaluate the efficacy and safety of plitidepsin in patients with COVID-19 requiring hospital admission

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release